Zheng Xiao-ling
Title:
Associate Chief Pharmaceutist
Bio:
Education Background:
1999-2003 Zhejiang University, Bachelor's degree
2009-2012 Zhejiang University, Master's Degree
Expertise：
Administration of medication during lactation and pregnancy
Research Interests：
Drug delivery andgene therapy
Research Narrative:
The main research direction is the sustained and controlled release of biological agents, especially the application of PLGA in protein and gene. One project of the National Natural Science Foundation of China was carried out, the third prize of Zhejiang Science and Technology was awarded for the construction and application of a composite carrier based on release control (4th accomplisher).
Publication:
1. Xiaoling Zheng, Yongzhuo Huang, Caihong Zheng, et al. Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination. The AAPS J 2010 , 12(4):519-524
2. Shuqing Zhou，Xiaoling Zheng，Caihong Zheng，et al. A thermosensitive gel formulation of an empirical traditional chinese precription for treating cervical erosion.Acta Pharmaceutica Sinica B. 2012; 2(5):495-501. 2/6
3.Zhao YC, Zhang L, Feng SS, Hong L, Zheng HL, Chen LL, Zheng XL, Ye YQ, Zhao MD, Wang WX, Zheng CH. Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome[J]. Int J nanomedicine,2016, 11:5485
4.Xiaoling Zheng,Yao Zhu, Yunchun Zhao, Caihong Zheng. Taxanes in combination with platinum derivatives for the treatment of ovarian cancer during pregnancy: a literature review. Int J clinical pharmacology and therapeutics, 2017,55(9):751-760.
Email:
ekwefi@zju.edu.cn
